Treatment of visceral leishmaniasis: Pitfalls and stewardship
Publication date
2016-07-01
Authors
Dorlo, Thomas P.C.
Ostyn, Bart A.
Uranw, Surendra
Dujardin, Jean-Claude
Boelaert, Marleen
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
amphotericin B lipid complex, miltefosine, alternative medicine, antibiotic resistance, bioequivalence, drug combination, disease elimination, drug efficacy, elimination half-life, human, Leishmania donovani, letter, monotherapy, priority journal, teratogenicity, treatment planning, visceral leishmaniasis, Taverne
Citation
Dorlo, T P C, Ostyn, B A, Uranw, S, Dujardin, J-C & Boelaert, M 2016, 'Treatment of visceral leishmaniasis : Pitfalls and stewardship', The Lancet Infectious Diseases, vol. 16, no. 7, pp. 777-778. https://doi.org/10.1016/S1473-3099(16)30091-3